Stockreport

United Therapeutics: Ralinepag Is The Ultimate Defense Against Yutrepia (Rating Upgrade) [Seeking Alpha]

United Therapeutics Corporation  (UTHR) 
Last united therapeutics corporation earnings: 4/29 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.unither.com/investor-relations
PDF Ralinepag's blockbuster potential, TYVASO's IPF expansion, and a strategic shift away from royalty-heavy products underpin UTHR's attractive valuation. My base case f [Read more]